October 2022 Journal Watch
Published 1 October 2022
The October 2022 Journal Watch explores MCS & Pharmacy topics including:
- Risk factors for bleeding complications during veno-venous extracorporeal membrane oxygenation as a bridge to recovery
- Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation
- Pre-operative risk factors for driveline infection in left ventricular-assist device patients
- Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients
Issue Editor:
Tara Veasey, PharmD
Additional Contributors:
ERIK HENRICKSEN, PharmD, BCPS
Stanford Medicine, Stanford, CA USA
ROSALIND WYATT MPharm PGDip
Wythenshawe Hospital, Manchester University NHS Foundation Trust, UK
ZAHRA IRSHAD MPharm
University Hospitals Birmingham, Birmingham, UK